This was a general cGMP inspection by the FDA and it has been concluded with no 483 observations.
Moneycontrol News
Shares of Divis Laboratories added 4 percent in the opening trade on Thursday as USFDA completed inspection with no 483 observations.
The company's unit-I at Choutuppal, Telangana had an inspection by USFDA from May 14-16.
This was a general cGMP inspection by the FDA and it has been concluded with no 483 observations.
The company's board meeting is scheduled to be held on May 26, 2018, to consider and approve standalone and consolidated audited financial results for the year ended March 31, 2018 and to recommend dividend, if any, on equity shares for the financial year 2017-18.
At 09:22 hrs Divis Laboratories was quoting at Rs 1,207.45, up Rs 41.30, or 3.54 percent on the BSE.
Posted by Rakesh Patil